See 1 citation found by title matching your search:
Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD).
Blum K1,2,3,4,5,6,7,8,9,10,
Madigan MA4,
Fried L7,
Braverman ER6,
Giordano J5,
Badgaiyan RD9.
- 1
- Department of Psychiatry & McKnight Brain Institute, University of Florida College of Medicine, USA.
- 2
- Department of Psychiatry and Behavioral Sciences, Keck Medicine University of Southern California, USA.
- 3
- Division of Applied Clinical Research & Education, Dominion Diagnostics, USA.
- 4
- Department of Neurogenetics, Igene, USA.
- 5
- National Institute for Holistic Addiction Studies, USA.
- 6
- Department of Clinical Neurology, Path Foundation NY, USA.
- 7
- Division of Neuroscience Based Addiction Therapy, The Shores Treatment & Recovery Center, USA.
- 8
- Eötvös Loránd University, Institute of Psychology, Europe.
- 9
- Department of Psychiatry, Wright State University Boonshoft School of Medicine and Dayton VA Medical Center, US.
- 10
- Division of Reward Deficiency Syndrome, Nupathways, Inc., Innsbrook, MO, USA.